{"id":666130,"date":"2023-09-04T19:44:01","date_gmt":"2023-09-04T19:44:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=666130"},"modified":"2023-09-04T19:44:01","modified_gmt":"2023-09-04T19:44:01","slug":"bipolar-disorder-market-to-witness-upsurge-in-growth-during-the-forecast-period-202332-examine-delveinsight-alzamend-vanda-pharmaceuticals-arvelle-janssen-nrx-pharma-sunovion-entheogenix","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/bipolar-disorder-market-to-witness-upsurge-in-growth-during-the-forecast-period-202332-examine-delveinsight-alzamend-vanda-pharmaceuticals-arvelle-janssen-nrx-pharma-sunovion-entheogenix_666130.html","title":{"rendered":"Bipolar Disorder Market to Witness Upsurge in Growth During the Forecast Period (2023-32), Examine DelveInsight | Alzamend, Vanda Pharmaceuticals, Arvelle, Janssen, NRx Pharma, Sunovion, Entheogenix"},"content":{"rendered":"
\n
\"Bipolar<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
As per DelveInsight, the Bipolar Disorder Market is anticipated to evolve immensely in the coming years owing to the increase in R&D activity, rising prevalent population, expected commercial success of upcoming therapies, along with a hike in the usage of approved therapies in the 7MM.<\/div>\n

DelveInsight’s “Bipolar Disorder Market Insights, Epidemiology, and Market Forecast 2032<\/strong>” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Bipolar Disorder market size, share, trends, and growth opportunities in the seven major markets (7MM) (i.e., the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan).<\/p>\n

The report covers emerging Bipolar Disorder drugs, current treatment practices, market share of individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current Bipolar Disorder treatment practice\/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

Bipolar Disorder: An Overview<\/strong><\/p>\n

Bipolar Disorder (formerly called manic-depressive illness or manic depression, is a mental disorder that causes unusual shifts in mood, energy, activity levels, concentration, and the ability to carry out day-to-day tasks. It is a condition that causes extreme mood swings that include emotional highs (mania or hypomania) and lows (depression). When the mood of a person shifts to mania or hypomania (less extreme than mania), the person may feel euphoric, full of energy, or unusually irritable. These mood swings can affect sleep, energy, activity, judgment, behavior, and the ability to think clearly.<\/p>\n

There are three types of bipolar disorder. All three types involve clear changes in mood, energy, and activity levels. These moods range from periods of extremely “up,” elated, irritable, or energized behavior (known as manic episodes) to very “down,” sad, indifferent, or hopeless periods (known as depressive episodes). Three different types of bipolar disorder include Bipolar I Disorder, Bipolar II Disorder, and Cyclothymic Disorder (also called Cyclothymia). Sometimes a person might experience symptoms of bipolar disorder that do not match the three categories, which are referred to as “other specified and unspecified bipolar and related disorders.”<\/p>\n

Bipolar Disorder Market Key Facts<\/strong><\/p>\n